logo

KR EN CN

ABOUT US

R&D

PRODUCTS

NOTICE

Towards Better Quality of Life GNT Pharma has devoted itself to the development of innovative new drugs for patients with
neurological, inflammatory, and respiratory diseases.

Our PIPELINE Thanks to their safety and multifaceted mechanisms to diverse range of diseases,
GNT Pharma's drug candidates have a high chance of success in clinical trials.

NELONEMDAZ Nelonemdaz / Drug for stroke

A new synthetic drug dually targeting two drivers of neuronal cell death after stroke: gutamate-mediated neurotoxicity and reactive oxygen species (ROS).

MORE VIEW

CRISDESALAZINE Crisdesalazine / Drug for Alzheimer’s disease (AD)

A new synthetic drug dually targeting two drivers of neurodegenerative diseases such as AD: inflammation and reactive oxygen species (ROS).

MORE VIEW

FLUSALAZINE Flusalazine / Drug for inflammatory - respiratory diseases and pain

A next-generation, new synthetic drug for inflammatory - respiratory diseases and pain that drastically reduces gastrointestinal and cardiovascular side effects of pre-existing anti-inflammatory analgesic drugs.

MORE VIEW

GNT Pharma’s Drug Development Towards better quality of life, GNT Pharma prioritizes its research and
development efforts in neurological, inflammatory, and respiratory diseases.

SITE MAP

Research

Research Area

Members

Professor

Research Professor & Ph.D.

Student

Alumni

Publication

International Journal

International Conference

Domestic Journal

Domestic Conference

Patents

Awards

Book

Softwares

Courses

Courses

Community

News & Notice

Gallery

Contact